First Time Loading...

LianBio
NASDAQ:LIAN

Watchlist Manager
LianBio Logo
LianBio
NASDAQ:LIAN
Watchlist
Price: 0.319 USD -8.28% Market Closed
Updated: Jun 1, 2024

LianBio
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

LianBio
Other Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
LianBio
NASDAQ:LIAN
Other Current Liabilities
$500k
CAGR 3-Years
-44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Current Liabilities
$3.3B
CAGR 3-Years
149%
CAGR 5-Years
406%
CAGR 10-Years
26%
Amgen Inc
NASDAQ:AMGN
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Liabilities
$648.6m
CAGR 3-Years
32%
CAGR 5-Years
8%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Liabilities
$516.7m
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
23%

See Also

What is LianBio's Other Current Liabilities?
Other Current Liabilities
500k USD

Based on the financial report for Dec 31, 2022, LianBio's Other Current Liabilities amounts to 500k USD.

What is LianBio's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 3Y
-44%

Over the last year, the Other Current Liabilities growth was -38%. The average annual Other Current Liabilities growth rates for LianBio have been -44% over the past three years .